Variable | N (204) | 10-year RFS % | p-value (log rank) | Prognostically unfavourable subgroup |
---|---|---|---|---|
Pathology | ||||
Follicular and Hurthle | 74 | 81 | ns | – |
Papillary | 129 | 77 | ||
Gender | ||||
Male | 34 | 78 | 0.04 | Male |
Female | 170 | 81 | ||
Age | ||||
< 45 | 109 | 78 | ns | |
≥ 45 | 95 | 79 | ||
T stage | ||||
T0 | 1 | 100 | ||
T1 | 49 | 85 | 0.038Ϯ | |
T2 | 76 | 85 | 0.011* | T4 |
T3 | 48 | 75 | ||
T4Ϯ* | 16 | 60 | ||
TX | 14 | 63 | ||
Extra-thyroid extension | ||||
No | 171 | 87 | 0.02* | Extra-thyroid |
Yes* | 23 | 64 | extension | |
Unknown | 10 | 53 | ||
Nodal status | ||||
N0Ϯ* | 130 | 93 | N1 | |
N1 | 63 | 76 | 0.004* | and |
NX (unknown) | 11 | 30 | < 0.001Ϯ | unknown |
Residual tumour | ||||
R0/1Ϯ | 175 | 88 | ||
R2Ϯ | 15 | 100 | Unknown | |
Unknown | 14 | 24 | < 0.001Ϯ | |
Post-operative risk stratification for risk of recurrence | ||||
High | 17 | 72 | 0.05* | High, intermediate |
IntermediateϮ | 98 | 74 | 0.02* | and |
Low* | 82 | 90 | unknown | |
Unknown | 7 | 24 | 0.006Ϯ; 0.001* |